Overview


According to FutureWise analysis the market for neurorehabilitation devices in 2023 is US$ 1.48 billion, and is expected to reach US$ 4.23 billion by 2031 at a CAGR of 14.%.

Neurorehabilitation has seen a significant transformation recently due to computer-aided and electronic robotic equipment usage. These tools help improve how well patients react to rehabilitation treatments. The sector has tremendous growth potential due to the rising incidence and prevalence of neurological disorders. Their most frequent use of physiotherapy enhances the patient's quality of life. Patients who have suffered a brain injury must undergo neurorehabilitation as a crucial element of their recovery.

Neurorehabilitation devices use technology in the physiotherapy industry. The majority of neurological rehabilitation tools aim to make learning or relearning motor functions easier regardless of the reason for the disability. Non-invasive brain stimulators, neurorobotic systems, brain-computer interfaces, and wearable technology are all types of neurorehabilitation equipment. One of the key factors accelerating the growth and demand for neurorehabilitation equipment is the increased prevalence and incidence rate of neurological illnesses. Additionally, the rising prevalence of neurological disorders, including Parkinson's disease, stroke, and multiple sclerosis, causes patients to have mobility impairments, which also contributes to the market's expansion.

FutureWise Market Research has published a report that provides an insightful analysis of neurorehabilitation devices market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the neurorehabilitation devices market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Hocoma AG (Switzerland)
  • Ekso Bionics Holdings, Inc. (the US)
  • ReWalk Robotics Ltd (Israel)
  • Eodyne (Spain)
  • Neuro Rehab VR (US)
  • Neofect (US)
  • Bioness Inc. (US)
  • Bionik Laboratories Corp. (Canada)
  • Reha Technology AG (Switzerland)
  • Rex Bionics Ltd (New Zealand)
  • Kinestica
  • Neurostyle Pte Ltd
  • Saebo, Inc.
  • MindMaze Holding SA
  • Neuro Device Group S.A.
  • DIH Technologies Corporation (Hocoma)
  • Tyromotion GmbH
  • Boston Scientific Corporation
  • Medtronic plc
  • St. Jude Medical Inc (Abbott Laboratories)
  • Ectron Ltd
  • MagVenture A/S
  • Helius Medical Technologies
  • Rehabtronics Inc
  • Rehab-Robotics Company Limited

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Neurorehabilitation Devices Market:

In July 2022- A clinical trial called "Neurorehabilitation Through Hippotherapy of a Brain Stroke (HippoPostCVA)" was sponsored by Alliance Equiphoria to assess and examine the impact of a hippotherapy program of multiple cycles delivered over 22 weeks overall on the functional and overall evolution of post-stroke patients (with a score of Ranking three at inclusion) during the outpatient rehabilitation phase.

The global aging population is increasing, resulting in a rise in the prevalence of mobility disorders and age-related neurological ailments. Some neurological conditions are either not currently treatable or incurable. Neurorehabilitation entirely saves the patients in these circumstances and allows them to carry out regular chores. The above causes are expected to increase demand for sufficient and efficient neuro-rehab technologies and services. Moreover, the advent of robotic rehabilitation and the rising need for neurorehabilitation due to the rise in neurological illnesses both offer significant growth opportunities for the market. Robot-assisted therapy can be utilized in addition to conventional physical therapy techniques. Robotics for rehabilitation includes a wide range of training tools for regaining lost bodily capabilities brought on by neurological or traumatic events. Robotic device use is a highly motivational tactic because it enables intensive, repeated, and task-specific training while posing a potential duty reduction for the therapist. The market for neurorehabilitation equipment is expanding due to several key factors, including the increasing rise in the elderly population and the efficiency of gaming systems in neurorehabilitation. Over the projection period, increased R&D is expected to offer substantial industry growth. However, giving adequate rehabilitation is becoming more difficult due to the rise of individuals with various medical conditions and impairments and the resulting restriction in access to providers. However, the lack of customized home care neurorehabilitation devices and low disposable income levels in emerging nations is expected to restrain the market's expansion. On the other hand, rigorous regulatory guidelines and rising demand for qualified specialists are anticipated to impede the market's expansion.

By Type

  • Neuro-Robotic Devices
  • Wearable Devices
  • Non-Invasive Stimulators
  • Brain-Computer Interfaces

By Application  

  • Brain Stroke
  • Parkinson's Disease
  • Multiple Sclerosis
  • Spinal Cord Injury
  • Cerebral Palsy
  • Schizophrenia
  • Others

By End User

  • Rehabilitation Centers
  • Hospitals & Clinics
  • Home Care

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022 due to the rising prevalence of diseases, including Parkinson's, Alzheimer's, and stroke, as well as the region's growing elderly population and technological developments in neurorehabilitation equipment. For instance, 6.5 million Americans aged 65 and older are predicted to have Alzheimer's in 2022, according to the Alzheimer's Association's 2022 report. 73% of people are 75 years of age or older. This figure is anticipated to increase to around 13 million by 2050. This market is also anticipated to expand in the region during the forecast period due to rising activities by the major players to raise awareness and the expanding use of neurorehabilitation.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Neurorehabilitation Devices Market By Type, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Neurorehabilitation Devices Market Variables, Trends and Scope
    •      1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Neurorehabilitation Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Neurorehabilitation Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Neurorehabilitation Devices Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Neuro-Robotic Devices
        2. Wearable Devices
        3. Non-Invasive Stimulators
        4. Brain-Computer Interfaces

  • 8.   Neurorehabilitation Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Brain Stroke
        2. Parkinson's Disease
        3. Multiple Sclerosis
        4. Spinal Cord Injury
        5. Cerebral Palsy
        6. Schizophrenia
        7. Others

  • 9.   Neurorehabilitation Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Rehabilitation Centers
        2. Hospitals and Clinics
        3. Home Care

  • 10.   North America Neurorehabilitation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Neurorehabilitation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Neurorehabilitation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Neurorehabilitation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Hocoma AG (Switzerland)
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Ekso Bionics Holdings, Inc. (the US)
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. ReWalk Robotics Ltd (Israel)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Eodyne (Spain)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Neuro Rehab VR (US)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Neofect (US)
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Bioness Inc. (US)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Bionik Laboratories Corp. (Canada)
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Reha Technology AG (Switzerland)
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Rex Bionics Ltd (New Zealand)
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Kinestica
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Neurostyle Pte Ltd
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Saebo, Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. MindMaze Holding SA
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Neuro Device Group S.A.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. DIH Technologies Corporation (Hocoma)
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Tyromotion GmbH
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Boston Scientific Corporation
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Medtronic plc
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. St. Jude Medical Inc (Abbott Laboratories)
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. Ectron Ltd
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22. MagVenture A/S
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
        23. Helius Medical Technologies
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
        24. Rehabtronics Inc
         24.1. Company Overview
         24.2. Product Portfolio
         24.3. SWOT Analysis
         24.4. Financial Overview
         24.5. Strategic Overview
        25. Rehab-Robotics Company Limited
         25.1. Company Overview
         25.2. Product Portfolio
         25.3. SWOT Analysis
         25.4. Financial Overview
         25.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients